Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: Follow-up of a clinical cohort

Sexually Transmitted Infections

Volumn 91, Issue 1, 2015, Pages 11-13

  Gundevia, Zarin ^a,d   Foster, Rosalind ^a,b   Jamil, Muhammad Shahid ^b   McNulty, Anna ^a,c  

^a Sydney Sexual Health Centre   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d SYDNEY EYE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; MOXIFLOXACIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONDOM USE; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GENITAL TRACT INFECTION; GRAM STAINING; HETEROSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYCOPLASMA GENITALIUM; MYCOPLASMA GENITALIUM INFECTION; MYCOPLASMOSIS; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; FEMALE UROGENITAL DISEASES; ISOLATION AND PURIFICATION; MALE UROGENITAL DISEASES; MICROBIOLOGY; MIDDLE AGED; MYCOPLASMA INFECTIONS; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AUSTRALIA; AZITHROMYCIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84928202016     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2014-051616     Document Type: Article

References (9)

1. Antibiotic Expert Group. Therapeutic guidelines: antibiotic. Version 14. Melbourne: Therapeutic Guidelines Limited, 2010.
2. Workowski K; Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR Recomm Rep 2010;59(RR-12):1-110. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5912a1.htm (accessed 6 Mar 2014).
3. Shamanesh M, Moi H, Lassau F, et al. 2009 European Guideline on the management of non-gonococcal urethritis. Int J STD AIDS http://www.iusti.org/regions/europe/pdf/2009/euro-ngu-0409.pdf (accessed 6 Mar 2014).
4. Couldwell DL, Tagg KA, Jeoffreys NJ, et al. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS 2013;24:822-8.
5. Manhart LE, Gillespie CW, Lowens MS, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 2013;56:934-42.
6. Anagrius C, Loré B, Jensen JS. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS ONE 2013;8:e61481.
7. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008;19:676-9.
8. Twin J, Jensen JS, Bradshaw CS, et al. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS ONE 2012;7:e35593.
9. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008;3:e3618.